Concepedia

Susumu Nakata

SN

Statistics

Publications

41

Citations

2.2K

H-Index

22

Active since

1994

Affiliations

Kyoto Pharmaceutical University(Current)

Kyoto Prefectural University of Medicine

Shiga University of Medical Science

Aichi Cancer Center

Target (United States)

Susumu Nakata is an author at Kyoto Pharmaceutical University specializing in oncology, life sciences, and molecular oncology.

ORCID

Publications per year

1994–2021

41

Publications

41

Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells

Susumu Nakata, Tatsushi Yoshida, Mano Horinaka et al. · Oncogene · 2004 · 268 citations

, , +17

Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups.

Hajime Tokita, Hiroaki Okamoto, Fumio Tsuda et al. · Proceedings of the National Academy of Sciences · 1994 · 187 citations · Full text

, , +17

Luteolin induces apoptosis via death receptor 5 upregulation in human malignant tumor cells

Mano Horinaka, Tatsushi Yoshida, Takumi Shiraishi et al. · Oncogene · 2005 · 180 citations

, , +14

Proteasome Inhibitor MG132 Induces Death Receptor 5 through CCAAT/Enhancer-Binding Protein Homologous Protein

Tatsushi Yoshida, Takumi Shiraishi, Susumu Nakata et al. · Cancer Research · 2005 · 174 citations · Full text

, , +17

RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survival

Violaine Goidts, Josephine Bageritz, Laura Puccio et al. · Oncogene · 2011 · 157 citations

, , +15

1–5 of 41